FDA launches global approval disclosure program to speed medicine access
The GRDP initiative will share regulatory review materials with global health authorities to accelerate access to medicines worldwide.
Article label: Quick Read
Premium article
With the goal of helping health regulators around the world make faster approval decisions on medicines and biologics, the US Food and Drug Administration (FDA) has launched a dedicated program.
The Global Reliance Disclosure Program (GRDP) allows the FDA to provide companies with “minimally redacted approval packages,” including scientific and
